Global Partnership resistance to antibiotics (GARP) develop practical proposals for policy of resistance to antibiotics for four low-and middle-income countries: India, Kenya, South Africa and Vietnam. Proposals to identify shortcomings in the way antibiotics are developed, governed and managed and how well the country to monitor the use of strattera side effects antibiotics and resistance. The experience and capacity developed in these first five countries will form the basis of a wider partnership with other low and middle income, providing a wider awareness among national policy makers about the need for policy controls resistance to antibiotics in the global effort. GARP is a project of the Center for Disease Control dynamics, economic policy. GARP Secretariat works in close collaboration with partner organizations and national working groups in each of the four countries of focus. GARP Phase 1 completed the 1st Global Forum on Bacterial infection: balancing access to treatment and antibiotic resistance 3-5 October 2011 in New Delhi, India. .
No comments:
Post a Comment